首页> 外文期刊>Research and Science Today >GLUCOCORTICOID THERAPY IN PATIENTS WITHRHEUMATOID ARTHRITIS – A CAUSE OF HYPERTENSION
【24h】

GLUCOCORTICOID THERAPY IN PATIENTS WITHRHEUMATOID ARTHRITIS – A CAUSE OF HYPERTENSION

机译:类风湿关节炎患者的糖皮质激素治疗-高血压的原因

获取原文
       

摘要

RHEUMATOID ARTHRITIS (RA) IS AN AUTOIMMUNE DISEASE THAT AFFECTS ESPECIALLY THE JOINTSBUT IT’S AUTOIMMUNE CHARACTER IS BEST SEEN IN ITS SYSTEMIC AFFECTION. PATIENTS WITH RAARE WELL KNOWN TO HAVE AN IMPORTANT RISK OF MORBIDITY AND MORTALITY FROMCARDIOVASCULAR DISEASE (CVD).NOWADAYS, GLUCOCORTICOIDS (GDS) ARE USED IN RHEUMATOLOGY AS “BRIDGE THERAPY” WHILEWAITING FOR ONSET OF ACTION OF DISEASE-MODIFYING ANTIRHEUMATIC DRUGS (DMARDS) , OR FORDISEASE FLARES 10. NUMEROUS STUDY SUGGEST THAT THE USE OF GCS ALONG WITH STANDARDTHERAPY CAN SUBSTANTIALLY REDUCE THE PROGRESSION OF EROSION IN RA.
机译:类风湿关节炎(RA)是一种自发性疾病,尤其是对关节的影响是其系统性影响最好的表现。众所周知,患有RAARE的患者会因心血管疾病(CVD)发生严重的死亡率和死亡率风险。如今,在风湿病学中,糖皮质激素(GDS)一直被用作“桥诊”,在疾病持续发作期间就一直在等待这种疾病的发生(持续)或FORDISEASE耀斑10.大量研究表明,与常规疗法一起使用GCS可以大大减少RA的侵蚀。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号